Impact Factor

2.6

Global Health & Medicine -> 2021 Vol.3(No.4)

Editorial
HIV-associated malignancies at 40: much accomplished but much to do
Global Health & Medicine. 2021; 3(4):184-186.
Review
International strategy in cancer epidemiology: Japan's involvement in global projects and future role
Global Health & Medicine. 2021; 3(4):187-195.
Management of frailty under COVID-19 pandemic in Japan
Global Health & Medicine. 2021; 3(4):196-202.
Promoting analysis of real-world data: Prospects for preventive cardiology in Japan
Global Health & Medicine. 2021; 3(4):203-213.
Current status and future perspectives of onco-cardiology: Importance of early detection and intervention for cardiotoxicity, and cardiovascular complication of novel cancer treatment
Global Health & Medicine. 2021; 3(4):214-225.
Original Article
A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancer
Global Health & Medicine. 2021; 3(4):226-235.
Communication
A single-center descriptive study of untraced sources of infection among new cases of coronavirus disease in Tokyo, Japan
Global Health & Medicine. 2021; 3(4):236-239.
Letter
COVID-19 and liver surgery in France, Italy, Japan, and the United States: A report of a single topic conference of Eastern and Western Association for Liver Tumors (EWALT) 2021
Global Health & Medicine. 2021; 3(4):240-242.
Gaps in the civil registration and vital statistics systems of low- and middle-income countries and the health sector's role in improving the situation
Global Health & Medicine. 2021; 3(4):243-245.
Advocacy of cyber public health
Global Health & Medicine. 2021; 3(4):246-248.